MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.

Conclusions: Our very preliminary results support the hypothesis that MASPIN expression in primary head and neck squamous cell carcinoma (HNSCC) may be a valuable parameter for predicting patients' responses to a treatment based on carboplatin plus vinorelbine combined with radiotherapy. Objectives:...

Descripción completa

Detalles Bibliográficos
Publicado en:Acta Oto-Laryngologica Vol. 129; no. 7; pp. 786 - 793
Autores principales: Marioni G, Koussis H, Gaio E, Giacomelli L, Bertolin A, D'Alessandro E, Scola A, Ottaviano G, de Filippis C, Jirillo A, Staffieri A, Blandamura S
Formato: pictorial research tables/charts Journal Article
Publicado: Taylor & Francis Ltd Jul2009
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105362322&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105362322
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00016489
        B6D
      jtl: Acta Oto-Laryngologica
      issn: 00016489
      maglogo: Y
    pubinfo:
      dt: Jul2009
      vid: 129
      iid: 7
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        105362322
        2010320379
        10.1080/00016480802412789
        NLM18819022
        105362322
      ppf: 786
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
      aug:
        au:
          Marioni G
          Koussis H
          Gaio E
          Giacomelli L
          Bertolin A
          D'Alessandro E
          Scola A
          Ottaviano G
          de Filippis C
          Jirillo A
          Staffieri A
          Blandamura S
        affil: Department of Medical and Surgical Specialties, Section of Otolaryngology, University of Padova, Via Giustiniani 2, 35100 Padova, Italy. E-mail: gino.marioni@unipd.it
      sug:
        subj:
          Carboplatin Therapeutic Use
          Carcinoma, Squamous Cell Therapy
          Head and Neck Neoplasms Therapy
          Protease Inhibitors Diagnostic Use
          Aged
          Carcinoma, Squamous Cell Risk Factors
          Chemotherapy, Cancer
          Data Analysis Software
          Drug Therapy, Combination
          Evaluation Research
          Female
          Fisher's Exact Test
          Head and Neck Neoplasms Radiotherapy
          Histological Techniques
          Kaplan-Meier Estimator
          Log-Rank Test
          Male
          Mann-Whitney U Test
          Middle Age
          Neoplasm Staging
          P-Value
          Neck Dissection
          Radiotherapy
          ROC Curve
          Sample Size
          Spearman's Rank Correlation Coefficient
          Survival
          Ultrasonography
          Human
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Conclusions: Our very preliminary results support the hypothesis that MASPIN expression in primary head and neck squamous cell carcinoma (HNSCC) may be a valuable parameter for predicting patients' responses to a treatment based on carboplatin plus vinorelbine combined with radiotherapy. Objectives: The roles of induction chemotherapy and combined chemoradiotherapy in the treatment of locally advanced unresectable HNSCCs have evolved rapidly. MASPIN has a unique tumour-suppressing activity. Experimental evidence has shown that MASPIN suppresses tumour growth, angiogenesis, invasion and metastasis. We investigated the potential prognostic roles of MASPIN and p53 in a series of HNSCCs treated with carboplatin plus vinorelbine combined with radiotherapy. Patients and methods: Nineteen consecutive stage III or IV HNSCC patients were recruited. The treatment plan consisted of the administration of carboplatin on day 1 and vinorelbine on days 1 and 8. Four weeks later, carboplatin was administered concomitantly with radiation therapy. Expression of MASPIN and p53 was determined immunohistochemically in HNSCC diagnostic biopsies. Results: A significant inverse relation was found between MASPIN expression and cN staging (p=0.003). From a prognostic viewpoint, MASPIN expression was directly correlated with chemoradiotherapy response (p=0.041). Moreover, the log-rank test showed a significant relationship between higher MASPIN expression and longer disease-free survival (p=0.03), overall survival (p=0.006) and disease-specific survival (p=0.007).
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N